Literature DB >> 7493450

Ro/SS-A and La/SS-B: autoantigens in Sjögren's syndrome?

R J Smeenk1.   

Abstract

Sjögren's syndrome is characterized serologically by the presence of autoantibodies against Ro/SS-A and La/SS-B. The mechanisms by which these autoantibodies arise is not clear at this moment. B cells capable of producing antibodies to Ro/SS-A and La/SS-B seem to be present in every individual; whether or not an individual indeed makes these antibodies is governed by T cells. Recent experiments from us and from others indicate that T cell tolerance towards Ro/SS-A and La/SS-B can be broken by immunization of normal mice with recombinant human Ro/SS-A or La/SS-B. The specificity of the T cells directing the anti-Ro/SS-A and anti-La/SS-B autoantibody response in these animals has not yet been elucidated. T cells may either be directed against foreign epitopes present on the human immunogen or they may be truly autoreactive. In patients with Sjögren's syndrome, a comparable immunization route might encompass product of viral origin directing the T cell response via RNA/protein complexes. Putative candidates comprise viruses that make use of RNAse polymerase-III, such as Epstein Barr virus, adenovirus, vesicular stomatitis virus en rabies virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7493450     DOI: 10.1007/BF03342632

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  44 in total

1.  IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.

Authors:  S Barakat; O Meyer; F Torterotot; P Youinou; J P Briand; M F Kahn; S Muller
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome.

Authors:  E Ben-Chetrit; R I Fox; E M Tan
Journal:  Arthritis Rheum       Date:  1990-03

3.  Analysis of protein--RNA interactions within Ro ribonucleoprotein complexes.

Authors:  G J Pruijn; R L Slobbe; W J van Venrooij
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

Review 4.  Reactivation of Epstein-Barr virus in Sjögren's syndrome.

Authors:  R I Fox; M Luppi; H I Kang; P Pisa
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Do B cells drive the diversification of immune responses?

Authors:  M J Mamula; C A Janeway
Journal:  Immunol Today       Date:  1993-04

Review 6.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

7.  B cells process and present lupus autoantigens that initiate autoimmune T cell responses.

Authors:  M J Mamula; S Fatenejad; J Craft
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

8.  Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation.

Authors:  T D Golan; K B Elkon; A E Gharavi; J G Krueger
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis.

Authors:  M Tateishi; I Saito; K Yamamoto; N Miyasaka
Journal:  Arthritis Rheum       Date:  1993-06

Review 10.  Autoimmune disease. A problem of defective apoptosis.

Authors:  J D Mountz; J Wu; J Cheng; T Zhou
Journal:  Arthritis Rheum       Date:  1994-10
View more
  1 in total

1.  Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection.

Authors:  Sergi Clotet-Freixas; Max Kotlyar; Caitriona M McEvoy; Chiara Pastrello; Sonia Rodríguez-Ramírez; Sofia Farkona; Heloise Cardinal; Mélanie Dieudé; Marie-Josée Hébert; Yanhong Li; Olusegun Famure; Peixuen Chen; S Joseph Kim; Emilie Chan; Igor Jurisica; Rohan John; Andrzej Chruscinski; Ana Konvalinka
Journal:  Transplant Direct       Date:  2021-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.